N-[5-(3,5-DIFLUOROBENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-2H-PYR… Application EP-3834827-A1 European Patent Office 16 Jun 2021
Pharmaceutical compositions and dosage forms Grant US-11007191-B2 United States of America 18 May 2021
Molecules for administration to ROS1 mutant cancer cells Grant US-10682348-B2 United States of America 16 Jun 2020